Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02576600Completed
Randomised, open-label trial (2 arms). Primary endpoint: Peroperative Remifentanil Consumption. Started Oct 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02576600.